We are going to start hearing stories about people getting their entire genome sequenced. What might these stories miss?
One thing that they might do, is try to interpret the data the same way they did for companies like 23andMe and focus on common variants.
The real story is in the rare alleles. One in ten of us are very affected by these, and the sequencing tests reveal them as long as we are looking for them. Almost all common diseases have a rare allele component to [them]. What happened before is that we went through a fad. Scientists were looking where the light was in the common variants and they mostly ignored rare alleles.
(Hat tip: @DivaBiotech)